Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.
FDA recall notice · announced August 26, 2026 · Sun Pharmaceutical Industries
Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.
The product
Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.
Reason for recall
CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
Notes
Distribution: US Nationwide.
Lot/code information: Lot # AD94033, Exp Date: 5/31/2028.
Quantity: 1968 Bottles (1000Tablets/Bottle)
Status: Ongoing
Products in this recall event:
- Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthor (D-0770-2026)
Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.